Brief: Orthocell Ltd Receives Approval For Remplir In 51 Department of Defence Hospitals
15/04/2026 02:28
April 15 (Reuters) - Orthocell Ltd OCC.AX: ORTHOCELL LTD - RECEIVES APPROVAL FOR REMPLIR IN 51 DOD HOSPITALS AND 170 VA MEDICAL CENTRES Source text: ID:nASX9XYDV7 Further company coverage: OCC.AX
Recent news on Orthocell
See all newsBrief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense
Australia's Orthocell gains most in over a year on US approval for nerve repair device
Brief: Orthocell Ltd Receives Approval For Remplir In 51 Department of Defence Hospitals